1-3 of 3
John Pollard, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

Sarah E Fordham, PhD, Helen J Blair, PhD, Claire J Elstob, PhD, Deepali Pal, PhD, Nicola Curtin, PhD, Paul Milne, PhD, Matthew Collin, MD PhD, Graham H Jackson, MD MBBS, Helen J Marr, MD PhD, Olaf Heidenreich, PhD, Ruth Plummer, John Pollard, PhD, Tobias F. Menne, MD PhD FRCPath, Gail L Jones, MD BMBS, James M Allan, DPhil
Journal: Blood
Blood (2016) 128 (22): 4031.
https://doi.org/10.1182/blood.V128.22.4031.4031
Published: 2016
Journal Articles

Combined Effects of a Pan-Aurora Kinase Inhibitor MK-0457 and Dasatinib Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.

Tetsuzo Tauchi, MD, Daigo Akahane, MD, Kousuke Nunoda, MD, Seiichi Okabe, MD, John Pollard, PhD, Kazuma Ohyashiki, MD
Journal: Blood
Blood (2007) 110 (11): 805.
https://doi.org/10.1182/blood.V110.11.805.805
Published: 2007
Journal Articles

MK-0457, a Novel Multikinase Inhibitor, Inhibits BCR-ABL Activity in Patients with Chronic Myeloid Leukemia (CML) and Acute Lymphocytic Leukemia (ALL) with the T315I BCR-ABL Mutation.

Donald A. Bergstrom, MD, PhD, Jason B. Clark, PhD, Alan Xiao, PhD, Matthew Griffiths, PhD, Susannah Falcon, PhD, John Pollard, PhD, Steven J. Freedman, MD,PhD, Francis Giles, MD
Journal: Blood
Blood (2006) 108 (11): 637.
https://doi.org/10.1182/blood.V108.11.637.637
Published: 2006